MO802: Genetics Plays a Limited Role in ESA-Hyporesponsiveness and Haemoglobin Outcomes in End-Stage Renal Disease Patients on Haemodialysis

Sivakumar Gowrisankar(Cincinnati Children's Hospital Medical Center), Rubeen Israni(GlaxoSmithKline (United States)), Jeffrey J. Connaire(DaVita Clinical Research (United States)), Lynn D. Condreay(PAREXEL International (United States)), Gilbert Marlowe(DaVita Clinical Research (United States)), Margaret G. Ehm(GlaxoSmithKline (United States)), Jennifer L. Aponte, Audrey Y. Chu(University of Helsinki), Dana J. Fraser(PAREXEL International (United States))
Nephrology Dialysis Transplantation
May 1, 2022
Cited by 0


Related Papers